LifeStance Health Group (Nasdaq: LFST) is considering a disciplined approach to mergers and acquisitions for the remainder of 2025. Company leadership hinted at more tuck-in deals to expand its footprint in new markets. Other deal activity could involve acquisitions related to digital therapeutics or specialty services, according to LifeStance CEO Dave Bourdon. He noted during LifeStance’s first quarter earnings call that any action related to M&A will be complementary, not a primary driver of growth.
Read the full article: LifeStance Signals Digital Therapeutics, Specialty Service M&A on the Horizon //
Source: https://bhbusiness.com/2025/05/07/lifestance-signals-digital-therapeutics-specialty-service-mas-are-on-the-horizon